Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/01/2855413/0/en/Compass-Pathways-to-participate-in-upcoming-23rd-Annual-Needham-Virtual-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2024/03/28/2853918/0/en/Compass-Pathways-Board-Chair-and-Co-Founder-George-Goldsmith-and-Co-Founder-Ekaterina-Malievskaia-Step-Down-from-Board-of-Directors.html
https://www.globenewswire.com//news-release/2024/02/29/2837818/0/en/Compass-Pathways-Announces-Fourth-Quarter-2023-Financial-Results-and-Business-Highlights.html
https://www.globenewswire.com//news-release/2024/02/26/2835473/0/en/Compass-Pathways-to-participate-in-upcoming-TD-Cowen-investor-conference.html
https://www.globenewswire.com//news-release/2024/02/22/2834060/0/en/Compass-Pathways-to-announce-fourth-quarter-and-year-end-2023-financial-results-on-February-29-2024.html
https://www.globenewswire.com/news-release/2024/01/31/2821544/0/en/Compass-Pathways-to-participate-in-upcoming-Oppenheimer-investor-conference.html
https://www.fiercebiotech.com/cro/compass-pathways-hackensack-meridian-ink-research-deal-psilocybin-treatment
https://www.globenewswire.com//news-release/2024/01/16/2809793/0/en/Compass-Pathways-enters-into-research-collaboration-agreement-with-Hackensack-Meridian-Health-to-develop-optimal-clinical-model-for-investigational-COMP360-psilocybin-treatment-if-.html
https://www.globenewswire.com//news-release/2024/01/05/2804617/0/en/Compass-Pathways-and-Greenbrook-TMS-enter-into-three-year-research-collaboration-agreement.html
https://www.fiercebiotech.com/biotech/compass-reads-out-safety-data-first-psilocybin-trial-ptsd-efficacy-data-come